國(guó)際學(xué)界同行科學(xué)家聯(lián)名聲援肖傳國(guó)

國(guó)際學(xué)界同行科學(xué)家聯(lián)名聲援肖傳國(guó)。
直言了，2010-09-30。 [原創(chuàng) 2010-10-01 07:54:16]
http://zhiyanle.blog.hexun.com/57249784_h.html


附后是國(guó)際學(xué)界31名學(xué)者聲援肖傳國(guó)的聯(lián)名公開(kāi)信。那些學(xué)者來(lái)自美國(guó)、加拿大、阿根廷、法國(guó)、德國(guó)、印度等國(guó)家的著名醫(yī)學(xué)機(jī)構(gòu)，其中許多學(xué)者是領(lǐng)域內(nèi)的領(lǐng)銜學(xué)者。

公開(kāi)信介紹了肖傳國(guó)取得的科研成就，簡(jiǎn)單回顧了成就過(guò)程和目前由美國(guó)衛(wèi)生部資助的“進(jìn)行時(shí)”科研狀況。公開(kāi)信說(shuō)，肖氏手術(shù)科研成就得到國(guó)際學(xué)界同行的公認(rèn)贊賞、并正在全球展開(kāi)；他為治病救人和醫(yī)療發(fā)展做出了很了不起的成績(jī)，中國(guó)人民和中國(guó)政府應(yīng)該為來(lái)自中國(guó)的醫(yī)生和科學(xué)家肖傳國(guó)而感到驕傲自豪。

由美國(guó)醫(yī)學(xué)界人士為主的“治療護(hù)理”網(wǎng)站的管理者WISE-YOUNG介紹了該公開(kāi)信。介紹文字說(shuō)：從醫(yī)學(xué)和科學(xué)的角度說(shuō)，評(píng)議科研由沒(méi)有利益沖突的同行評(píng)議實(shí)行。而方舟子和他的律師彭劍的評(píng)議（所謂“打假”），不但沒(méi)有足夠證據(jù)支持，而且，他們跟業(yè)務(wù)完全不沾邊，他們二人之間還有利益關(guān)系、同時(shí)還跟肖某有官司利益沖突，因此，他們根本就沒(méi)有資格做評(píng)議。那些介紹文字還說(shuō)，醫(yī)學(xué)業(yè)內(nèi)人士都知道，肖傳國(guó)工作很努力，他的科研成績(jī)有他自己的學(xué)術(shù)報(bào)告和同行評(píng)議的證明。我這里介紹一封聲援肖某的聯(lián)名公開(kāi)信，聯(lián)名者包括領(lǐng)域內(nèi)最有名望的科學(xué)家。

要說(shuō)“同行評(píng)議”，那么，包括國(guó)際學(xué)界享有名望的科學(xué)家的聯(lián)名信，是以特殊形式對(duì)肖傳國(guó)的科研做了個(gè)評(píng)價(jià)，那就是充分地公認(rèn)肖某取得的成就和貢獻(xiàn)。當(dāng)然，也無(wú)疑，那封國(guó)際學(xué)界同行聯(lián)名的公開(kāi)信，有力地駁斥了對(duì)肖傳國(guó)科研搞了九年左右的所謂“學(xué)術(shù)造假”的輿論轟炸和造謠誹謗。

本人認(rèn)為，中國(guó)人民和中國(guó)政府是器重科技人才的。譬如，所謂“肖某打人”案件發(fā)生后，在強(qiáng)國(guó)論壇等官方媒體平臺(tái)，絕大多數(shù)網(wǎng)民自發(fā)的同情聲援肖傳國(guó)和怒斥方舟子等人對(duì)肖某搞的多年的造謠誹謗行為，就是個(gè)現(xiàn)實(shí)生動(dòng)的例子。

問(wèn)題是一些利益關(guān)系媒體及其人員，特別是最近一段時(shí)間的南方報(bào)業(yè)、央視白巖松和科學(xué)新聞總編等人，跟在無(wú)業(yè)人員方舟子的屁后搖尾巴，用偽造數(shù)據(jù)和偽造證據(jù)、對(duì)肖傳國(guó)實(shí)行媒體暴力、搞持續(xù)的造謠誹謗和輿論轟炸；還有光明媒體，自稱是“知識(shí)分子家園”，卻多次用虛假信息發(fā)表新聞評(píng)論，不但對(duì)肖傳國(guó)實(shí)行媒體暴力攻擊和搞造謠誹謗的輿論轟炸、甚至還對(duì)肖某搞謾罵和人格侮辱。

中國(guó)政府早已頒布新聞管理法規(guī)，明確規(guī)定不得發(fā)表未經(jīng)核實(shí)屬實(shí)的新聞評(píng)論，不得對(duì)公民搞謾罵和人格侮辱；可是，那些媒體及人員卻反其道而行之，明目張膽地搞違犯國(guó)家法規(guī)的活動(dòng)。

在中國(guó)、美國(guó)或任何文明國(guó)家，治理學(xué)術(shù)不端行為是授權(quán)執(zhí)法即國(guó)家主權(quán)范圍的事情；把作假程度超過(guò)任何已處理案情的無(wú)業(yè)人員方舟子包裝成“打假人士”而在中國(guó)社會(huì)搞執(zhí)法活動(dòng)，以所謂“打假”的名義到處插手、對(duì)做出成績(jī)的中國(guó)科技人才搞無(wú)端指控和輿論轟炸，而且，那種以媒體暴力為主要特征的活動(dòng)、一搞就是十來(lái)年，那簡(jiǎn)直就是個(gè)天大的荒唐事、更是個(gè)最大的作假案。

簡(jiǎn)而言之，那些媒體及人員搞的媒體暴力的惡行不但嚴(yán)重地傷害了肖傳國(guó)，而且，嚴(yán)重?cái)_亂中國(guó)社會(huì)和給中國(guó)法治社會(huì)建設(shè)造成干擾破壞，還給中國(guó)的國(guó)際聲譽(yù)造成了嚴(yán)重的負(fù)面影響。

包括不少領(lǐng)銜科學(xué)家在內(nèi)的國(guó)際學(xué)界同行聲援肖傳國(guó)，畢竟是所謂的“外部因素”，肖傳國(guó)案件的事情發(fā)展如何主要還是看中國(guó)的“內(nèi)部因素”。就此，在中國(guó)，不少網(wǎng)民已經(jīng)指明，所謂三個(gè)“鐵證”都與方舟子等人的自述大不符合，即有很明顯的偽造案情和栽贓逼供的嫌疑。就是說(shuō)，期望公正公平處理肖案的，不但是國(guó)際學(xué)界的“外部因素”，更是中國(guó)自己的“內(nèi)部因素”。

重復(fù)說(shuō)，前兩天，中國(guó)最高層領(lǐng)導(dǎo)發(fā)話，再次強(qiáng)調(diào)要正確處理人民內(nèi)部矛盾。我看，那講話也應(yīng)該是處理肖傳國(guó)案件的政策指南，也應(yīng)該是避免以后再發(fā)生類似肖案事件的政策指南。



附件一：國(guó)際學(xué)界31名領(lǐng)銜學(xué)者聲援肖傳國(guó)的聯(lián)名公開(kāi)信（中文）。
說(shuō)明：我不知譯者是誰(shuí)，有閱讀問(wèn)題，請(qǐng)以原文為準(zhǔn)或跟翻譯者聯(lián)系（有連接地址）。


31位國(guó)際學(xué)術(shù)同仁聲援肖傳國(guó)醫(yī)生的公開(kāi)信【中文翻譯稿】 (8192 bytes)
Posted by: Mendel / Date: September 30, 2010 04:56AM
http://www.starlakeporch.net/bbs/read.php?1,67653,67653#msg-67653
此處下載原文PDF文檔 [sci.rutgers.edu]

國(guó)際學(xué)術(shù)同仁聲援肖傳國(guó)醫(yī)生的公開(kāi)信
2010年9月29日

致所有人：

我們都有幸認(rèn)識(shí)肖傳國(guó)大夫多年。他是一位受國(guó)際學(xué)術(shù)界尊敬的外科醫(yī)生和科學(xué)家，在恢復(fù)（脊椎損傷病人的）排尿和排便功能的神經(jīng)再生研究中，他取得了重大進(jìn)展。肖傳國(guó)醫(yī)生在美國(guó)完成了開(kāi)創(chuàng)性的動(dòng)物實(shí)驗(yàn)研究，闡明支配大腿的運(yùn)動(dòng)神經(jīng)可以用來(lái)繞接支配膀胱和排便。這個(gè)繞接可以形成一個(gè)反射作用（反射弧）來(lái)啟動(dòng)來(lái)膀胱功能。他研究的成果已經(jīng)多次發(fā)表在同行評(píng)議的國(guó)際科學(xué)期刊上。其他的科學(xué)家也已經(jīng)重復(fù)并證實(shí)了肖醫(yī)生的這些研究結(jié)果。

肖醫(yī)生最終鼓起勇氣將動(dòng)物實(shí)驗(yàn)研究的成果轉(zhuǎn)化到臨床試驗(yàn)上，在中國(guó)的脊柱損傷和脊柱裂病人身上開(kāi)展神經(jīng)繞接（神經(jīng)通路重建，即反射?。┦中g(shù)。在中國(guó)，由于缺乏抗痙攣藥物antimuscarinics和間歇性導(dǎo)尿術(shù)（自插導(dǎo)尿管），神經(jīng)性膀胱功能障礙成為一種威脅生命的疾病。能緩解神經(jīng)性膀胱功能障礙的并發(fā)癥的療法，就是一種能夠拯救生命的成功。神經(jīng)性膀胱和排大便功能障礙患者的病情是很痛苦的，包括遭受尿潴留、尿失禁、反復(fù)感染、腎功能不全、大便失禁、便秘等，生活質(zhì)量極差。神經(jīng)通路重建手術(shù)是一個(gè)非常復(fù)雜的手術(shù)，需要神經(jīng)的再生。不應(yīng)當(dāng)把手術(shù)的成功定義為完全恢復(fù)排便排尿功能。這項(xiàng)手術(shù)的重點(diǎn)在于收益超過(guò)風(fēng)險(xiǎn)。

肖醫(yī)生的臨床研究成果發(fā)表在多種學(xué)術(shù)刊物上，并兩次獲得Jack Lapides佳作獎(jiǎng)，這是獎(jiǎng)勵(lì)在神經(jīng)泌尿科學(xué)界作出重要貢獻(xiàn)的科學(xué)家的最崇高的國(guó)際性大獎(jiǎng)之一。2008年，因?yàn)樗目茖W(xué)成就，肖醫(yī)生還獲得了國(guó)際兒童排尿節(jié)制學(xué)會(huì)頒發(fā)的Kelm Hjalmas演講者（受邀做大會(huì)主題發(fā)言）榮譽(yù)。我們當(dāng)中的許多人都曾經(jīng)到中國(guó)去檢視肖醫(yī)生治療過(guò)的患者的情況，觀摩或者學(xué)習(xí)他發(fā)明的神經(jīng)通路重建手術(shù)。肖醫(yī)生是一位非常有經(jīng)驗(yàn)的外科醫(yī)生，他對(duì)患者熱情照顧，不知疲倦地培訓(xùn)來(lái)自世界各地的醫(yī)生們，來(lái)推廣他的神經(jīng)通路重建手術(shù)。

在美國(guó)，已經(jīng)開(kāi)展過(guò)一項(xiàng)獨(dú)立而且嚴(yán)格的先期試驗(yàn)來(lái)檢驗(yàn)這項(xiàng)手術(shù)的安全性和效益。術(shù)后一年的治療結(jié)果最近發(fā)表在《泌尿科學(xué)雜志》（ Journal of Urology）上。在12個(gè)月的隨訪期間，在9位脊髓裂患者中，有7位患者，觀察到皮下至膀胱的神經(jīng)反射弧的構(gòu)建成立，證明神經(jīng)通路重建手術(shù)的確起了作用。這個(gè)成績(jī)是了不起的，肖醫(yī)生應(yīng)該得到嘉獎(jiǎng)。并且，一部分患者已經(jīng)展現(xiàn)出大小便排便功能的改善，并將隨時(shí)間推移而變得更好。術(shù)后36個(gè)月的成果正在分析中，不久就會(huì)發(fā)表。該先期試驗(yàn)的數(shù)據(jù)是支持“肖氏手術(shù)”的，現(xiàn)在受NIH（美國(guó)國(guó)立衛(wèi)生研究院）資助的臨床試驗(yàn)正在開(kāi)展，以進(jìn)一步在脊髓裂患者中研究腰椎至骶神經(jīng)通路重建。還有，在肖醫(yī)生的幫助和指導(dǎo)下，類似的臨床試驗(yàn)也在世界范圍內(nèi)開(kāi)展。

中國(guó)人民和政府應(yīng)該為肖醫(yī)生對(duì)病人所作出的貢獻(xiàn)、對(duì)他的科學(xué)成就，和他在世界上培訓(xùn)醫(yī)生以推廣這項(xiàng)手術(shù)的誠(chéng)意而自豪。國(guó)際科學(xué)界對(duì)肖醫(yī)生被拘捕的消息感到震驚。我們這些了解肖醫(yī)生的人，都對(duì)他涉入此案感到難以置信。

肖醫(yī)生是一個(gè)極富同情心的紳士，他的誠(chéng)實(shí)和對(duì)本學(xué)科作出的開(kāi)創(chuàng)性的科學(xué)成就廣受世界同行的尊敬。我們懇請(qǐng)中國(guó)政府和有關(guān)權(quán)威機(jī)構(gòu)公正對(duì)待肖大夫，并在案情調(diào)查期間保障他的基本人權(quán)。在此事件中，請(qǐng)重視肖大夫?qū)κ澜缢鞒龅目茖W(xué)和人道主義事業(yè)的貢獻(xiàn)。

謹(jǐn)致


Kenneth M. Peters, MD
Professor and Chairman of Urology
Beaumont Hospital
Royal Oak, Michigan
（美國(guó)Beaumont醫(yī)院泌尿科主任）

Jack S. Elder, M.D.
Chief of Urology, Henry Ford Health System
Associate Director, Vattikuti Urology Institute
Department of Urology, Children's Hospital of Michigan
Clinical Professor of Urology, Case School of Medicine
(美國(guó)密西根兒童醫(yī)院泌尿科主任)

Edwin A. Smith M.D.
Assistant Clinical Professor of Urology
Emory University School of Medicine
Atlanta, Georgia
（美國(guó)艾默里大學(xué)醫(yī)學(xué)院臨床助理教授）

Kevin M. Feber, MD, FAAP
Board Certified in Pediatric Urology
Comprehensive Urology
William Beaumont Children's Hospital
（美國(guó)William Beaumont兒童醫(yī)院醫(yī)生）

Ananias C. Diokno, M.D., F.A.C.S.Executive Vice President & CMOBeaumont HospitalRoyal Oak, Michigan 48073 USA
（美國(guó)Beaumont醫(yī)院執(zhí)行副總裁）

Juan José de Benito
Urologist
Hospital Nacional de Clínicas
Córdoba, Argentina.
（阿根廷國(guó)立醫(yī)院）

William E. Nantau B.Sc., CNIMClinical ManagerClinical Neurophysiology DepartmentBeaumont Hospital Royal Oak
（美國(guó)Beaumont醫(yī)院臨床神經(jīng)生理科臨床主管）

Evan J Kass MD,FACS,FAAPChief, Division of Pediatric UrologyBeaumont Childrens HospitalProfessor of Urology, Oakland University-William Beaumont School of Medicine
（美國(guó)Beaumont兒童醫(yī)院泌尿科主任，奧克蘭大學(xué)醫(yī)學(xué)院教授）

Jacques Corcos MD.Professor of Urology, McGill UniversityGeneral Secretary of the International Continence SocietyJewish General hospital3755 Cote Ste-CatherineMontreal, Quebec, Canada H3T 1E2
（加拿大麥基爾大學(xué)泌尿?qū)W教授，國(guó)際兒童排尿節(jié)制學(xué)會(huì)秘書(shū)長(zhǎng)）

Jose Gonzalez, M.D.
Department of Urology
Beaumont Hospital
Royal Oak, Michigan
（美國(guó)Beaumont醫(yī)院泌尿科醫(yī)生）

Christopher Payne, MD
Associate Professor of Urology
Stanford University Medical School
Stanford, CA 94305-5118
（美國(guó)斯坦福大學(xué)醫(yī)學(xué)院泌尿?qū)W副教授）

Kenneth I. Glassberg, MD
Director, Division of Pediatric Urology
Morgan Stanley Children's Hospital of New York-Presbyterian
Professor of Urology, Columbia University
College of Physicians and Surgeons
3959 Broadway, CHN 1118
（美國(guó)哥倫比亞大學(xué)醫(yī)學(xué)院泌尿?qū)W教授，兒童泌尿?qū)W分科主任）
Earl Y. Cheng, MD
Associate Professor of Urology
Children’s Memorial Hospital
Chicago, Illinois
（美國(guó)芝加哥兒童醫(yī)院泌尿?qū)W副教授）

Darius J. Bagli, MDCM
Professor of Surgery
Senior Associate Scientist
Director of Urology Research
Divisions of Urology and
Developmental & Stem Cell Biology
The Hospital For Sick Children
Institute of Medical Science
University of Toronto
（加拿大多倫多大學(xué)外科學(xué)教授，泌尿?qū)W研究主任）

Henri B. LOTTMANN, MD, FEBU, FEBPS, FRCS(england) FEBPU
Paediatric urology unit
Hopital Necker-Enfants-Malades
149, rue de Sèvres
75015 Paris
France
（法國(guó)Necker-Enfants-Malades醫(yī)院兒童泌尿科醫(yī)生）

Dr. Amrish Vaidya MS. MCh.Consultant Paediatric Surgeon,Kokilaben Dhirubhai Ambani Hospital,4 Bungalows, Andheri W, Mumbai, India
（印度Kokilaben Dhirubhai Ambani醫(yī)院醫(yī)生）
Marc Cendron, MD
Associate Professor in Urology
Harvard Medical School
Children’s Hospital Boston
Boston, MA
（美國(guó)哈佛大學(xué)醫(yī)學(xué)院泌尿?qū)W副教授）

Stuart B. Bauer, MD
Associate Director, Neurourology
Professor of Urology
Harvard Medical School
Children’s Hospital Boston
Boston, MA
（美國(guó)哈佛大學(xué)醫(yī)學(xué)院泌尿?qū)W教授，波士頓兒童醫(yī)院神經(jīng)泌尿科副主任）

Edmond T. Gonzales, Jr., MD
Professor of Urology
Baylor College of Medicine
（美國(guó)貝勒醫(yī)學(xué)院泌尿?qū)W教授）

Richard Macchia, MD FACS
SUNY Distinguished Teaching Professor
Cleveland Clinic, Florida
（美國(guó)Cleveland臨床中心教授）

Benjamin Girdler, MD
Urology Center of the Rockies
Fort Collins, Colorado
（美國(guó)科羅拉多洛基泌尿中心醫(yī)生）

William C. de Groat, Ph.D.
Professor of Pharmacology
University of Pittsburgh
（美國(guó)匹茲堡大學(xué)藥理學(xué)教授）

Michael R. Ruggieri, Sr., Ph.D.
Director of Urologic Research
Temple University School of Medicine
（美國(guó)坦普大學(xué)醫(yī)學(xué)院泌尿?qū)W研究主任）

Stanley J Kogan MDChief, Pediatric UrologyChildren's Hospital at MontefioreBronx NY USA
（美國(guó)Montefiore兒童醫(yī)院兒童泌尿科主任）

Anthony Caldamone, MD
University Urologic Associates, Inc.2 Dudley St Ste 185Providence, RI 02905
（美國(guó)布朗大學(xué)泌尿?qū)W中心醫(yī)生）

Yves Homsy MD, FRCSC, FAAP Clinical Professor of Urological Surgery and Pediatrics University of South Florida Children's Urology Group 5507 E. Longboat Blvd Tampa FL 33615
（美國(guó)南弗羅里達(dá)大學(xué)臨床泌尿?qū)W教授）

Dr. Enrique Turina
Professor of urology of the National University of Buenos Aires
Chief of section Urology of Instituto de Rehabilitación
Government of Buenos Aires, Argentina.
（阿根廷國(guó)立Buenos Aires大學(xué)泌尿?qū)W教授）

Dr. Angel Ozón
Urologist of the Instituto de Rehabilitación of Buenos Aires
（阿根廷國(guó)立Buenos Aires大學(xué)泌尿?qū)W醫(yī)生）

Dr. Daniel Ekizian
Urologist of Instituto de Rehabilitación.
（阿根廷國(guó)立Buenos Aires大學(xué)泌尿?qū)W醫(yī)生）

Professor Dr. med. Karl-Dietrich Sievert
Vice Chair Prof. of Urology, Director - Uro-oncology, Neurourology, Incontinence, & Reconstructive Urology Department of Urology University of Tuebingen D72076 Tuebingen, Germany
（德國(guó)Tuebingen大學(xué)泌尿?qū)W教授、主任）

Holly Gilmer, MD
Chief of Pediatric Neurosurgery
Beaumont Hospital
Royal Oak, Michigan
（美國(guó)Beaumont醫(yī)院兒童神經(jīng)外科主任）

Yegappan Lakshmanan, MD
Chief, Pediatric Urology
Children’s Hospital of Michigan
（美國(guó)密西根兒童醫(yī)院兒童泌尿科主任）。



附件二：美國(guó)專職“治療護(hù)理”網(wǎng)站的管理者介紹該公開(kāi)信的文字。
那些文字指明：從醫(yī)學(xué)和科學(xué)的角度說(shuō)，評(píng)議科研由沒(méi)有利益沖突的同行評(píng)議實(shí)行。而方舟子和他的律師彭劍的評(píng)議（所謂“打假”），不但沒(méi)有足夠證據(jù)支持，而且，他們跟業(yè)務(wù)完全不沾邊，他們二人之間有利益關(guān)系、同時(shí)他們共同還跟肖某有官司利益沖突，因此，他們根本就沒(méi)有資格做評(píng)議。那些介紹文字還說(shuō)，醫(yī)學(xué)業(yè)內(nèi)人士都知道，肖傳國(guó)工作很努力，他的科研成績(jī)有他自己的學(xué)術(shù)報(bào)告和同行評(píng)議的證明。我這里介紹一封聲援肖某的聯(lián)名公開(kāi)信，聯(lián)名者包括領(lǐng)域內(nèi)最有名望的科學(xué)家。。

Today, 12:28 AM #35
Wise Young /Administrator/Location: New Brunswick, NJ, USA
http://sci.rutgers.edu/forum/showthread.php?t=140519&page=4

I have been reluctant to comment on this matter in large part because there is insufficient evidence. The so-called "investigation" of Dr. Xiao's results that you describe was carried out by a lawyer who is not qualified to assess patients and apparently affiliated with Mr. Fang, a long-time critic of Dr. Xiao. Normally, in science and medicine, results are confirmed by other investigators who do similar studies to ascertain whether the results can be replicated.

To his credit, Dr. Xiao has been working very hard over the past 5 years to teach his procedure to other doctors and to encourage them to do and publish clinical trials of the Xiao method of treating bladder paralysis. The results of the first clinical trial by Dr. Peters at the Oakland University William Beaumont Hospital in Michigan, was recently published in the Journal of Urology. I understand that other studies in Scandinavia will be published soon. Dr. Xiao has published his work. It is not difficult to find the studies.

I urge people to come to their own conclusions concerning the results. I do not want to impose my opinions concerning the results until people have had a chance to read the work and discuss the results. In the meantime, I attach a letter from the international academic community concerning Dr. Xiao and the news concerning his incarceration. This letter is very supportive of Dr. Xiao and has been signed by some of the most prominent urologists and scientists in the field.

Wise.
Attached Images Xiao Support Letter.PDF (75.6 KB, 99 views) /[sci.rutgers.edu]。
http://sci.rutgers.edu/forum/attachment.php?attachmentid=37089&d=1285820875

   

附件三：國(guó)際學(xué)界31名同仁聯(lián)名聲援肖傳國(guó)的公開(kāi)信（英文原文）。
http://sci.rutgers.edu/forum/attachment.php?attachmentid=37089&d=1285820875 

Open letter in support of Chuan-Guo Xiao, M.D. from the International Academic Community
September 29, 2010

To all,

We have all had the pleasure of knowing Dr. Chuan-Guo Xiao for many years. He is an internationally respected surgeon-scientist who has made major advances in the development of neuroregeneration to restore voiding and bowel function. Dr. Xiao performed groundbreaking animal research in the United States, demonstrating that a motor nerve that innervates the leg can be used to reinnervate the bladder and bowel. This reinnervation allows for development of a reflex to initiate bladder function. The results of his studies were published in peer-reviewed journals and other scientists have replicated Xiao’s findings confirming these results.

Dr. Xiao eventually took the courageous step of moving from animal research to human studies and began performing the rerouting procedure on patients with spinal cord injury and spina bifida in China. Neurogenic bladder is life threatening in China due to a lack of both antimuscarinics and intermittent catheterization, and lessening the complications of neurogenic bladder would be considered a lifesaving success.

Patients with neurogenic bladder and bowel suffer greatly and endure a host of issues such as urinary retention, incontinence, recurrent infections, renal insufficiency, fecal incontinence, constipation, and poor quality of life. For a procedure as complicated as nerve rerouting requiring nerve regeneration, one cannot expect normalization of bladder and bowel function to be the definition of success. What is important is that the benefits outweigh the risks of the procedure.

Dr. Xiao published his clinical results in peer-reviewed journals and was twice honored by the Jack Lapides Essay Contest, one of the most respected international awards given to scientists who make major contributions to the field of neurourology. In 2008, he was named the Kelm Hjalmas Memorial Lecturer from the International Children’s Continence Society for his scientific achievements. Many of us have traveled to China to examine patients treated by Dr. Xiao and/or have been trained by him in the nerve rerouting surgery he invented. Dr. Xiao is a very skilled surgeon who is passionate about patient care and works tirelessly to train physicians around the world in performing his nerve rerouting procedure.

In the United States, an independent and very rigorous pilot research trial was performed to test the safety and efficacy of this procedure. The one-year results were recently published in the Journal of Urology. At the 12-month follow-up visit, a cutaneous to bladder reflex was found in 7 of 9 spina bifida patients, confirming that rerouting does occur. This finding by itself is remarkable and Dr. Xiao should be commended. In addition, a number of patients demonstrated improvement in bladder and bowel function, which has continued to improve with longer patient follow-up. The 36-month results are currently being analyzed and will be reported in the near future. The pilot data was supportive of Dr. Xiao’s procedure, and now an NIH sponsored clinical trial is being conducted to further study lumbar to sacral nerve rerouting in spina bifida patients. In addition, similar procedures have been done worldwide, with Dr. Xiao helping to mentor the surgeons at each site.

The Chinese people and government should be proud of Dr. Xiao for his dedication to his patients, his scientific achievements, and his willingness to train doctors around the world how to perform his surgery. The International scientific community was shocked to hear of Dr. Xiao’s arrest. Those of us who know Dr. Xiao well find it difficult to believe that he is involved in these attacks.

Dr. Xiao is a compassionate man who is respected worldwide for his integrity and his innovative scientific contributions to society. We implore the Chinese government and authorities to treat Dr. Xiao fairly and to protect his human rights as these charges are investigated. Please strongly consider Dr. Xiao’s scientific and humanitarian contributions to the world as facts are gathered in this case.

Sincerely,

Kenneth M. Peters, MD
Professor and Chairman of Urology
Beaumont Hospital
Royal Oak, Michigan USA

Jack S. Elder, M.D.
Chief of Urology, Henry Ford Health System
Associate Director, Vattikuti Urology Institute
Department of Urology,
Children's Hospital of Michigan
Detroit, MI USA

Edwin A. Smith M.D.
Assistant Clinical Professor of Urology
Emory University School of Medicine
Atlanta, Georgia USA

Kevin M. Feber, MD, FAAP
Beaumont Children's Hospital
Royal Oak, MI USA

Ananias C. Diokno, M.D., F.A.C.S.
Executive Vice President & CMO
Beaumont Hospital
Royal Oak, Michigan 48073 USA

Juan José de Benito
Urologist
Hospital Nacional de Clínicas
Córdoba, Argentina.

William E. Nantau B.Sc., CNIM
Clinical Manager
Clinical Neurophysiology Department
Beaumont Hospital Royal Oak, MI USA

Evan J Kass MD,FACS,FAAP
Chief, Division of Pediatric Urology
Beaumont Childrens Hospital
Professor of Urology, Oakland University-William
Beaumont School of Medicine, USA

Jacques Corcos MD.
Professor of Urology, McGill University
General Secretary of the International Continence Society
Jewish General hospital
3755 Cote Ste-Catherine
Montreal, Quebec, Canada H3T 1E2

Jose Gonzalez, M.D.
Department of Urology
Beaumont Hospital
Royal Oak, Michigan USA

Christopher Payne, MD
Associate Professor of Urology
Stanford University Medical School
Stanford, CA 94305-5118 USA

Kenneth I. Glassberg, MD
Director, Division of Pediatric Urology
Morgan Stanley Children's Hospital of New York-Presbyterian
Professor of Urology, Columbia University
College of Physicians and Surgeons
3959 Broadway, CHN 1118 NY USA

Earl Y. Cheng, MD
Associate Professor of Urology
Children’s Memorial Hospital
Chicago, Illinois USA

Darius J. Bagli, MDCM
Professor of Surgery
Senior Associate Scientist
Director of Urology Research
Divisions of Urology and Developmental & Stem Cell Biology
The Hospital For Sick Children
Institute of Medical Science
University of Toronto

Henri B. LOTTMANN, MD, FEBU, FEBPS,
FRCS(england) FEBPU
Paediatric urology unit
Hopital Necker-Enfants-Malades
149, rue de Sèvres
75015 Paris, France

Dr. Amrish Vaidya MS. MCh.
Consultant Paediatric Surgeon,
Kokilaben Dhirubhai Ambani Hospital,
4 Bungalows, Andheri W, Mumbai, India

Marc Cendron, MD
Associate Professor in Urology
Harvard Medical School
Children’s Hospital Boston
Boston, MA USA

Stuart B. Bauer, MD
Associate Director, Neurourology
Professor of Urology
Harvard Medical School
Children’s Hospital Boston
Boston, MA USA

Edmond T. Gonzales, Jr., MD
Professor of Urology
Baylor College of Medicine
Houston TX USA

Richard Macchia, MD FACS
SUNY Distinguished Teaching Professor
Cleveland Clinic, Florida
Benjamin Girdler, MD
Urology Center of the Rockies
Fort Collins, Colorado USA

William C. de Groat, Ph.D.
Professor of Pharmacology
University of Pittsburgh
Pittsburgh, PA USA

Michael R. Ruggieri, Sr., Ph.D.
Director of Urologic Research
Temple University School of Medicine
Philadelphia, PA USA

Stanley J Kogan MD
Chief, Pediatric Urology
Children's Hospital at Montefiore
Bronx NY USA

Anthony Caldamone, MD
University Urologic Associates, Inc.
2 Dudley St Ste 185
Providence, RI 02905 USA

Yves Homsy MD, FRCSC, FAAP
Clinical Professor of Urological Surgery and Pediatrics
University of South Florida
Children's Urology Group
5507 E. Longboat Blvd
Tampa FL 33615 USA

Dr. Enrique Turina
Professor of urology of the National University of Buenos Aires
Chief of section Urology of Instituto de Rehabilitación
Government of Buenos Aires, Argentina.

Dr. Angel Ozón
Urologist of the Instituto de Rehabilitación of Buenos
Aires

Dr. Daniel Ekizian
Urologist of Instituto de Rehabilitación.
Professor Dr. med. Karl-Dietrich Sievert
Vice Chair
Prof. of Urology, Director - Uro-oncology,
Neurourology, Incontinence, & Reconstructive Urology
Department of Urology University of Tuebingen
D72076 Tuebingen, Germany

Holly Gilmer, MD
Chief of Pediatric Neurosurgery
Beaumont Hospital
Royal Oak, Michigan USA

Yegappan Lakshmanan, MD
Chief, Pediatric Urology
Children’s Hospital of Michigan
Detroit, MI USA

# # #

× 烏有之鄉(xiāng) WYZXWK.COM

您的打賞將用于網(wǎng)站日常運(yùn)行與維護(hù)。
幫助我們辦好網(wǎng)站，宣傳紅色文化！

歡迎掃描下方二維碼，訂閱烏有之鄉(xiāng)網(wǎng)刊微信公眾號(hào)